In the group continuing hormone therapy
, for example, the median age was 58, more than 90% were white, and more than 50% used estrogen only.
The trial will study the progression of coronary artery disease, cognitive function, quality of life and breast density in women on hormone therapy
as it compares different forms of hormones.
is effective for hot flashes, and its short-term use may be worth the risks for some women with severe symptoms.
The 10 postmenopausal women in the study, ages 50-60, were given hormone therapy
or a placebo for four weeks, followed by a month with no medications, and then four weeks of the other treatment.
Schiff and other doctors point out that the WHI study wasn't meant to determine the effectiveness of hormone therapy
for treating menopausal symptoms, which is well documented.
Even 50 percent of female ob-gyns surveyed by the American College of Obstetricians and Gynecologists in December 2003 said they used hormone therapy
to treat their own menopausal symptoms.
Shortly after the July 2002 publication of the Women's Health Initiative findings, the health plan sent a letter to members who were using combined estrogen-progestin therapy, describing the study's findings and suggesting either that they stop using hormone therapy
or that they consult with their provider about continuing.
Postmenopausal hormone therapy
is a major, personal decision for women, and they should be armed with the latest key facts and useful tools to make the best decision for their needs," McClellan stated.
National Institutes of Health announced the early end of a large study, part of the Women's Health Initiative, on the effects of estrogen plus progestin hormone therapy
in healthy menopausal women.
The district court granted summary judgment for the defendants, upholding the Bureau's policy of requiring documentation of hormone therapy
received prior to incarceration before administering hormone therapy
, in the form of estrogen combined with progestin, is not recommended to prevent chronic conditions such as heart disease and diabetes in postmenopausal women, according to updated draft recommendations from the U.
Extended use of systemic hormone therapy
represents one area that clinicians commonly encounter.
in postmenopausal women does not prevent heart disease but does increase the risk of stroke and blood clots, according to a recently updated Cochrane review.
Current guidelines recommend that hormone therapy
, the primary medical treatment for hot flashes, not continue for more than 5 years.